Back to AMRN Stock Lookup

Amarin Corp plc (AMRN) – Press Releases

Aug 27, 2015 07:00 AM Amarin Announces Encore Presentation of Results of the Apolipoprotein C-III Post-Hoc Analysis From MARINE and ANCHOR Studies of Vascepa(R) at the European Society of Cardiology (ESC) 2015 Annual Congr
Aug 11, 2015 07:00 AM Amarin Promotes Joseph T. Kennedy to Executive Vice President, General Counsel and Strategic Initiatives
Aug 7, 2015 10:49 AM First Amendment Decision a Win for Amarin and Physician Plaintiffs
Aug 6, 2015 04:01 PM Amarin Reports Second Quarter 2015 Financial Results and Provides Update on Operations
Aug 5, 2015 04:27 PM Poseida Therapeutics, Inc., Expands Board of Directors
Aug 5, 2015 04:27 PM Poseida Therapeutics, Inc., Expands Board of Directors
Jul 31, 2015 07:00 AM Amarin Announces Upcoming Presentations of Two Eicosapentaenoic Acid (EPA) Studies at the American Society for Preventive Cardiology (ASPC) Annual Cardiovascular Disease Prevention Conference and the
Jul 30, 2015 07:00 AM Amarin to Report Second Quarter 2015 Results and Host Conference Call on August 6, 2015
Jul 9, 2015 10:00 AM Rodman & Renshaw 2015 Annual Global Investment Conference to be held in New York from September 8 to 10, 2015
Jun 11, 2015 07:00 AM New In Vitro Eicosapentaenoic Acid Study Data to Be Presented at the National Lipid Association Scientific Sessions in Chicago
Jun 8, 2015 07:00 AM New In Vitro Eicosapentaenoic Acid Study Data Presented June 6 at the American Diabetes Association Scientific Sessions in Boston
May 28, 2015 02:29 PM Amarin Granted Summary Judgment Motion in Suit Against FDA Seeking New Chemical Entity Market Exclusivity for Vascepa(R) (Icosapent Ethyl) Capsules
May 26, 2015 05:00 PM Amarin to Present at the Jefferies 2015 Global Healthcare Conference
May 8, 2015 06:00 AM Amarin Reports First Quarter 2015 Financial Results and Provides Update on Operations
May 5, 2015 05:00 PM Amarin to Report First Quarter 2015 Results and Host Conference Call on May 8, 2015
Apr 8, 2015 08:00 AM Amarin and Non-Profit, Walk with a Doc Partner to Expand National Health Awareness Efforts
Mar 16, 2015 04:30 PM New In Vitro Study Presented at the American College of Cardiology Meeting Suggests Omega-3 Fatty Acid EPA Pre-Treatment Reduces Oxidative Damage and May Provide Atheroprotective Benefit Versus Other
Mar 6, 2015 05:00 AM Amarin Announces $52.8 Million Private Placement
Dec 15, 2014 07:10 AM Annual Changes to the NASDAQ Biotechnology Index
May 15, 2014 05:00 AM Amarin Announces Private Exchange Transactions Regarding Outstanding Senior Exchangeable Notes
May 9, 2014 07:00 AM Amarin Reports First Quarter 2014 Financial Results and Provides Update on Operations
Mar 31, 2014 04:30 PM Amarin and Kowa Pharmaceuticals America, Inc. Announce U.S. Co-Promotion Agreement for Vascepa(R) (icosapent ethyl) Capsules
Feb 27, 2014 04:01 PM Amarin Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Update on Operations
Feb 21, 2014 04:01 PM Amarin Announces FDA Award of Three-Year Exclusivity for Vascepa(R) (icosapent ethyl) Capsules
Feb 6, 2014 06:30 AM Amarin to Present at the 2014 Leerink Global Healthcare Conference
Feb 4, 2014 06:00 AM Amarin Announces Promotion of Aaron Berg to Senior Vice President, Marketing and Sales
Jan 15, 2014 04:05 PM Amarin Announces FDA Review Division Response on ANCHOR SPA Agreement Reinstatement Request Will Be Delayed
Dec 20, 2013 06:00 AM Amarin Receives FDA Notification That Action on ANCHOR sNDA Review Will be Delayed
Dec 16, 2013 09:00 AM Amarin Announces Leadership Changes

Back to AMRN Stock Lookup